These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 32799915)

  • 1. A seven-year surveillance study of the epidemiology, antifungal susceptibility, risk factors and mortality of candidaemia among paediatric and adult inpatients in a tertiary teaching hospital in China.
    Zeng Z; Ding Y; Tian G; Yang K; Deng J; Li G; Liu J
    Antimicrob Resist Infect Control; 2020 Aug; 9(1):133. PubMed ID: 32799915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology, antifungal susceptibility, risk factors, and mortality of persistent candidemia in adult patients in China: a 6-year multicenter retrospective study.
    Li Y; Gu C; Yang Y; Ding Y; Ye C; Tang M; Liu J; Zeng Z
    BMC Infect Dis; 2023 Jun; 23(1):369. PubMed ID: 37264301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology, species distribution, antifungal susceptibility and mortality risk factors of candidemia among critically ill patients: a retrospective study from 2011 to 2017 in a teaching hospital in China.
    Xiao Z; Wang Q; Zhu F; An Y
    Antimicrob Resist Infect Control; 2019; 8():89. PubMed ID: 31161036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance study of the prevalence, species distribution, antifungal susceptibility, risk factors and mortality of invasive candidiasis in a tertiary teaching hospital in Southwest China.
    Zeng ZR; Tian G; Ding YH; Yang K; Liu JB; Deng J
    BMC Infect Dis; 2019 Nov; 19(1):939. PubMed ID: 31699043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China.
    Ma CF; Li FQ; Shi LN; Hu YA; Wang Y; Huang M; Kong QQ
    BMC Infect Dis; 2013 Jul; 13():337. PubMed ID: 23875950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial epidemiology of candidaemia in neonatal and paediatric intensive care units at the Children's Medical Center, Tehran.
    Charsizadeh A; Mirhendi H; Nikmanesh B; Eshaghi H; Makimura K
    Mycoses; 2018 Jan; 61(1):22-29. PubMed ID: 28872714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-Year Retrospective Analysis of Epidemiology, Risk Factors, and Antifungal Susceptibilities of Candidiasis from a Tertiary Care Hospital in South China.
    Bilal H; Zhang D; Shafiq M; Khan MN; Chen C; Khan S; Wang Q; Cai L; Islam R; Hu H; Zeng Y
    Microbiol Spectr; 2023 Aug; 11(4):e0070823. PubMed ID: 37310269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida orthopsilosis fungemias in a Spanish tertiary care hospital: incidence, epidemiology and antifungal susceptibility.
    Blanco-Blanco MT; Gómez-García AC; Hurtado C; Galán-Ladero MA; Lozano Mdel C; García-Tapias A; Blanco MT
    Rev Iberoam Micol; 2014; 31(2):145-8. PubMed ID: 23680638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candidemia in Adults at a Tertiary Hospital in China: Clinical Characteristics, Species Distribution, Resistance, and Outcomes.
    Lin S; Chen R; Zhu S; Wang H; Wang L; Zou J; Yan J; Zhang X; Farmakiotis D; Tan X; Mylonakis E
    Mycopathologia; 2018 Aug; 183(4):679-689. PubMed ID: 29572768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candidaemia in a Polish tertiary paediatric hospital, 2000 to 2010.
    Dzierzanowska-Fangrat K; Romanowska E; Gryniewicz-Kwiatkowska O; Migdał M; Witulska K; Ryżko J; Kaliciński P; Książyk J; Nadkowska P; Dzierzanowska D
    Mycoses; 2014 Feb; 57(2):105-9. PubMed ID: 23834472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology, species distribution, clinical characteristics and mortality of candidaemia in a tertiary care university hospital in Turkey, 2007-2014.
    Yeşilkaya A; Azap Ö; Aydın M; Akçil Ok M
    Mycoses; 2017 Jul; 60(7):433-439. PubMed ID: 28338249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features, antifungal susceptibility, and outcome of Candida guilliermondii fungemia: An experience in a tertiary hospital in mid-Taiwan.
    Tseng TY; Chen TC; Ho CM; Lin PC; Chou CH; Tsai CT; Wang JH; Chi CY; Ho MW
    J Microbiol Immunol Infect; 2018 Aug; 51(4):552-558. PubMed ID: 28625801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twenty-two years of candidaemia surveillance: results from a Norwegian national study.
    Hesstvedt L; Gaustad P; Andersen CT; Haarr E; Hannula R; Haukland HH; Hermansen NO; Larssen KW; Mylvaganam H; Ranheim TE; Sandven P; Nordøy I; ; Kanestrøm A; Grub C; Onken A; Thielsen C; Skaare D; Tofteland S; Sønsteby LJ; Hjetland R; Hide R; Vik E; Kümmel A; Åsheim S
    Clin Microbiol Infect; 2015 Oct; 21(10):938-45. PubMed ID: 26093076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological features of nosocomial candidaemia in neonates, infants and children: A multicentre study in Iran.
    Ahangarkani F; Shokohi T; Rezai MS; Ilkit M; Mahmoodi Nesheli H; Karami H; Tamaddoni A; Alizadeh-Navaei R; Khodavaisy S; Meis JF; Badali H
    Mycoses; 2020 Apr; 63(4):382-394. PubMed ID: 31985076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, virulence factors and antifungal susceptibility of Candida spp. isolated from bloodstream infections in a tertiary care hospital in Brazil.
    Canela HMS; Cardoso B; Vitali LH; Coelho HC; Martinez R; Ferreira MEDS
    Mycoses; 2018 Jan; 61(1):11-21. PubMed ID: 28940753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital.
    Bedini A; Venturelli C; Mussini C; Guaraldi G; Codeluppi M; Borghi V; Rumpianesi F; Barchiesi F; Esposito R
    Clin Microbiol Infect; 2006 Jan; 12(1):75-80. PubMed ID: 16460550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing candidaemia incidence from 2004 to 2015 with a shift in epidemiology in patients preexposed to antifungals.
    Goemaere B; Becker P; Van Wijngaerden E; Maertens J; Spriet I; Hendrickx M; Lagrou K
    Mycoses; 2018 Feb; 61(2):127-133. PubMed ID: 29024057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility and clinical outcomes of Candida parapsilosis bloodstream infections in a tertiary teaching hospital in Northern Taiwan.
    Lin CC; Liu CP; Hsieh FC; Lee CM; Wang WS
    J Microbiol Immunol Infect; 2015 Oct; 48(5):552-8. PubMed ID: 25315213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain.
    Puig-Asensio M; Padilla B; Garnacho-Montero J; Zaragoza O; Aguado JM; Zaragoza R; Montejo M; Muñoz P; Ruiz-Camps I; Cuenca-Estrella M; Almirante B; ; ;
    Clin Microbiol Infect; 2014 Apr; 20(4):O245-54. PubMed ID: 24125548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.